What was the overall market valuation of the cell counting market in 2024?

The overall market valuation was $2705.75 Million in 2024. Read More

What is the projected market valuation for the cell counting market by 2035?

The projected valuation for 2035 is $5533.7 Million. Read More

What is the expected CAGR for the cell counting market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 6.72%. Read More

What were the revenue figures for consumables and instruments in the product segment?

In 2024, consumables generated $1624.31 Million, while instruments accounted for $1081.44 Million. Read More

How do research and clinical applications compare in terms of market valuation?

Research applications were valued at $810 Million, whereas clinical & diagnostic applications reached $350 Million in 2024. Read More

What is the market size for pharmaceutical & biotechnology companies as end-users?

Pharmaceutical & biotechnology companies had a market size of $1082.3 Million in 2024. Read More

What was the market valuation for hospitals as end-users in 2024?

Hospitals accounted for a market valuation of $675 Million in 2024. Read More

What is the projected growth for the instruments segment by 2035?

The instruments segment is expected to grow from $1081.44 Million in 2024 to a higher valuation by 2035. Read More

What trends are anticipated in the cell counting market for the next decade?

The market is likely to experience growth driven by advancements in technology and increasing demand from research and clinical applications. Read More

Europe Cell Counting Market

Q: Which companies are considered key players in the cell counting market?

Key players include Beckman Coulter, Thermo Fisher Scientific, Merck KGaA, Becton Dickinson, Countstar, Sysmex Corporation, Bio-Rad Laboratories, Nexcelom Bioscience, and ChemoMetec A/S. Read More

ID: MRFR/LS/0160-HCR

90 Pages

Vikita Thakur

Last Updated: April 06, 2026

Europe, the Middle East and Africa Cell Counting Market Research Report Information By Product (Spectrophotometers, Flow Cytometers, Microplates) Application (Hematologic, Microbiology) By End Users (Hospitals & Clinics, Research Organizations, Academic Institutes) – Regional Forecast till 2035

Europe Cell Counting Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.72%

2024 Market Size$ 2,705.75 Million

2025 Market Size$ 2,887.58 Million

2035 Market Size$ 5,533.7 Million

Key Players

Beckman Coulter

Thermo Fisher Scientific

Merck KGaA

Becton Dickinson

Countstar

Sysmex Corporation

Trends

Technological Advancements
Regulatory Changes
Rising Demand in Research

Opportunities

Rising Incidence of Chronic Diseases
Increased Investment in Biotechnology
Growing Focus on Personalized Medicine

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product (USD Million)
  1. 4.1.1 Consumables
  2. 4.1.2 Instruments
2. 4.2 Healthcare, BY Application (USD Million)
  1. 4.2.1 Research Application
  2. 4.2.2 Clinical & Diagnostic Applications
  3. 4.2.3 Others
3. 4.3 Healthcare, BY End-User (USD Million)
  1. 4.3.1 Pharmaceutical & Biotechnology Companies
  2. 4.3.2 Hospitals
  3. 4.3.3 Research Institutes
  4. 4.3.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Beckman Coulter (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Merck KGaA (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Becton Dickinson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Countstar (CN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sysmex Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bio-Rad Laboratories (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Nexcelom Bioscience (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 ChemoMetec A/S (DK)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 EUROPE MARKET ANALYSIS BY PRODUCT
3. 6.3 EUROPE MARKET ANALYSIS BY APPLICATION
4. 6.4 EUROPE MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF HEALTHCARE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF HEALTHCARE
8. 6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 SUPPLY / VALUE CHAIN: HEALTHCARE
11. 6.11 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
12. 6.12 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Million)
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY END-USER, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Europe Cell Counting Market Segmentation

Europe Cell Counting Market By Product (USD Million, 2025-2035)

Consumables
Instruments

Europe Cell Counting Market By Application (USD Million, 2025-2035)

Research Application
Clinical & Diagnostic Applications
Others

Europe Cell Counting Market By End-User (USD Million, 2025-2035)

Europe Cell Counting Market & Biotechnology Companies
Hospitals
Research Institutes
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”